-
Recent Posts
- Dementia-Related Hospital Admissions (BBC News / Alzheimer’s Society)
- NHS Demands Action to Reduce Betting-Related Ill Health (BBC News / NHS England / Respublica)
- Research and Innovation Across the NHS and Academia (BBC News / Academy of Medical Sciences)
- eHealth / Internet-Based Interventions to Support Carers of People With Dementia (Internet Interventions)
- Christmas and Dementia: Some Benefits and Coping Strategies (BBC News / NHS England)
Archives
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Department of Health and Social Care (DHSC)
- Health Education England (HEE)
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Employers
- NHS England
- NHS Evidence
- NHS Improvement
- NICE Guidelines
- NIHR
- NIHRSDO
- Northern Ireland
- Patients Association
- Public Health England
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Wales
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Google Translate (100+ Languages)
Category Archives: Alzheimer’s Disease International (ADI)
Alzheimer’s Disease International (ADI)
Recent Contributions to the National Narrative on Dementia From the BBC (BBC News / BBC1 TV / BBC Music Memories)
Summary A competent journalistic summary on the impact of dementia on society, and faltering steps towards addressing the problem. Full Text Link Reference Gallagher, J. (2019). Dementia: The greatest health challenge of our time. London: BBC Health News, May 2nd … Continue reading →
Posted in Alzheimer’s Disease International (ADI), BBC News, For Carers (mostly), For Nurses and Therapists (mostly), In the News, Management of Condition, Non-Pharmacological Treatments, Person-Centred Care, Quick Insights, Statistics, UK, Universal Interest
|
Tagged ADI’s World Alzheimer Reports, BBC Dementia-Friendly Music Resources, BBC Health News, BBC Music Memories, BBC News Stories, BBC Norfolk News, BBC One TV, Benefits of Music for People With Dementia, Building Dementia Friendly Communities, Continuing Employment After Dementia Diagnosis, Dementia and Music, Dementia Cannula Sleeves, Dementia Prevalence, Dementia Statistics, Dementia Statistics (UK), Dementia-Friendly Cities, Dementia-Friendly Communities, Dementia-Friendly Towns, Designing Prevention Programmes to Reduce Incidence of Dementia, Developing Dementia Friendly Environments, Efficacy of Music Therapy, Employment After Dementia Diagnosis, Handmade for Dementia, Impact of Dementia, Lifesize Knitted Dolls, Marston Court Care Home (Oxford), Music Therapy, Music Therapy and Dementia, Musical Therapies, Our Dementia Choir with Vicky McClure: BBC One TV, Petal and Purl Craft Group (Caston Near Attleborough), Preferred Music, Prevalence and / or Incidence of Dementia, Prevalence of Dementia, Reminiscence, Reminiscence Archive (BBC), Reminiscence Therapy, Reminiscence Therapy Via Virtual Reality, Significant Arts (Reminiscence), Significant Music (Reminiscence), Staying at Work After Dementia Diagnosis, Vicky McClure's Dementia Choir, Virtual Reality, Virtual Reality in Dementia Care, Virtual Reminiscence Therapy, World Alzheimer Report 2015
|
Leave a comment
The State of Dementia Research Globally: World Alzheimer Report 2018 (Alzheimer’s Disease International)
Summary The World Alzheimer Report 2018, entitled “The state of the art of dementia research: New frontiers”, reviews developments in dementia research, without glossing-over the absence of significant disease-modifying pharmacological treatment breakthroughs for around 20 years. This report examines wide-ranging … Continue reading →
Posted in Acute Hospitals, Alzheimer’s Disease International (ADI), Charitable Bodies, Community Care, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, Person-Centred Care, Quick Insights, Standards, Statistics, UK, Universal Interest
|
Tagged ADI’s World Alzheimer Reports, Alireza Atri: Director of Banner Sun Health Research Institute, Alzheimer's Research, Alzheimer’s Disease International (ADI), Alzheimer’s Disease Research Unit: McGill Centre for Studies in Ageing (Canada), Alzheimer’s Prevention Initiative: Banner Health (USA), Alzheimer’s Prevention Initiative: Banner Sun Health Research Institute, Banner Sun Health Research Institute, Burden of Alzheimer’s Disease, Burden of Dementia (Statistics), Centre for Dementia Prevention: University of Edinburgh, Dementia as Cause of Death, Dementia Awareness, Dementia Awareness Raising, Dementia Collaborative Research Centre: University of New South Wales, Dementia Discovery Fund, Dementia Discovery Fund (DDF), Dementia Prevention, Dementia Research, Dementia Research Funding, Dementia Research Priorities, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies for Dementia, Disease-Modifying Treatments for Dementia, Dr Christopher Chen: Director of Memory Ageing and Cognition Centre at National University Health System: Singapore, Dr Doug Brown: Chief Executive Officer of British Society for Immunology, Dr Doug Brown: Former Chief Policy and Research Officer at Alzheimer’s Society, Dr Jennifer Bute: Dementia Alliance International (DAI), Dr Kenji Toba: President of National Centre for Geriatrics and Gerontology (Obu), Dr Maria Carrillo: Chief Science Officer at Alzheimer’s Association US, Dr Miia Kivipelto: Karolinska Institute, Dr Miia Kivipelto: Karolinska University Hospital (Stockholm), Dr Rachelle Doody: Global Head of Neurodegeneration at Roche, Dr Serge Gauthier: Director of Alzheimer’s Disease Research Unit at McGill Centre for Studies in Ageing in Canada, Drug Trials Failure Rate, Epidemiology, Epidemiology and Statistics, Francesca Colombo: Organisation for Economic Co-operation and Development (OECD), Fundación para la Lucha contra las Enfermedades Neurológicas (FLENI), Glenn Rees: Chairman of Alzheimer’s Disease International, Glenn Rees: Former CEO of Alzheimer’s Australia, Global Burden of Dementia, Global Dementia Discovery Fund (2015), Identification and Intervention for Dementia in Elderly Africans (IDEA Group), Jeff Cummings: Director of Cleveland Clinic at Lou Ruvo Centre for Brain Health, Kate Bingham: SV Health Managers, King’s College London, Market Failure (Dementia Research and Drug Development), Martin Knapp: London School of Economics, Memory Ageing and Cognition Centre at National University Health System: Singapore, Memory Ageing and Cognition Centre: National University Health System (Singapore), National Centre for Geriatrics and Gerontology (Japan), Optima (University of Oxford’s Dementia Research Project), OPTIMA Cohort (Oxford Project to Investigate Memory and Ageing), Oxford Project to Investigate Memory and Ageing (OPTIMA Study), Paola Barbarino: Alzheimer’s Disease International, Prevention, Prevention Agenda, Prevention of Future Dementia Cases by Increasing Knowledge of Risk and Protective Factors, Professor Adesola Ogunniyi: University College Hospital (Ibadan), Professor Bart De Strooper: Director of the UK Dementia Research Institute (UK DRI), Professor Craig Ritchie: Chair of Psychiatry of Ageing at University of Edinburgh, Professor Craig Ritchie: Director at Centre for Dementia Prevention, Professor Gordon Wilcock: Co-founder of Alzheimer’s Society UK, Professor Gordon Wilcock: Emeritus Professor of Geratology at University of Oxford, Professor Henry Brodaty: Director of Dementia Collaborative Research Centre at University of New South Wales, Professor Martin Knapp: Director of the Personal Social Services Research Unit at the London School of Economics and Political Science (LSE), Professor Martin Prince: Assistant Principal for Global Health at King’s College London, Research Networks, Ricardo Allegri: Head of Cognitive Neurology Neuropsychology and Neuropsychiatry at Fundación para la Lucha contra las Enfermedades Neurológicas (FLENI), Risk and Protective Factors, State of the Art of Dementia Research: New Frontiers (World Alzheimer Report 2018), Supporting People Affected by Dementia, UK Dementia Research Institute, UK Dementia Research Institute (UK DRI), UK Dementia Research Institute at UCL, University College Hospital (Ibadan Nigeria), World Alzheimer Report, World Alzheimer Report 2018: State of the Art of Dementia Research, World Alzheimer Report: 2018, World Alzheimer’s Day 2018
|
Leave a comment
Dementia Medication De-Listed in France: Untruth, Half-Truth or Paternalistic News Blackout? (BBC News / Prescrire / ADI / Inside Health / JAMA Network Open)
Summary Early evening headlines yesterday, on BBC Radio 4 news, announced the “shocking” news that drugs for Alzheimer’s Disease / dementia had been de-listed in France. This story has not been followed-up, and appears to have been dropped quietly; although … Continue reading →
Posted in Alzheimer’s Disease International (ADI), Universal Interest
|
Tagged Adverse Drug Reactions, Adverse Effects, Alpha-7 Nicotinic Acetylcholine Receptor (α7nAChR), Alzheimer's Disease: Monotherapy Versus Combination Therapy, Alzheimer's Research and Therapy, Alzheimer’s Disease International (ADI), Alzheimer’s Disease International (ADI) Campaigns, American Family Physician, Anti-Dementia Medication, Augusta University, BBC Radio 4, BBC Radio 4's Inside Health Programme, BBC Radio 4’s PM Programme, Big Pharma, BMJ, BMJ Publishing Group Ltd, British Medical Journal (BMJ), Cambridge Institute of Public Health: University of Cambridge, Care of the Elderly Medicine Department: Royal Wolverhampton NHS Trust, Cholinergic-Nicotinic System, Choosing Wisely, Clinic for Medicine of the Elderly (Hannover), Conflict of Interests, Conflicts of Interest, Department of Behavioral Neuroscience and Drug Development: Polish Academy of Sciences, Department of Psychiatry and Behavioral Health: Marshfield Clinic Health System, Department of Psychiatry and Behavioral Sciences: George Washington University School of Medicine and Health Sciences, Department of Psychiatry and Health Behavior: Augusta University, Department of Public Health and Primary Care: University of Cambridge, Deprescribing, Donepezil, Donepezil-Memantine Combination, Donepezil-Memantine: Monotherapy Versus Combination Therapy, Drug Efficacy, Drug Side-Effects, Drugs Alleged to Raise False Hopes (Speculative Construct), Family Medicine Residency Program: Southern Illinois University School of Medicine, Family Physicians Inquiries Network (FPIN), Formindep: Non-Profit Organisation Promoting Independence From Industry Influence, France, France's National Authority for Health (HAS), French Ministry of Health and Solidarity, French National Dementia Guidelines, Galantamine, Galantamine-Memantine Combination Versus Donepezil-Memantine Combination, Galantamine-Memantine Drug Combination, George Washington University School of Medicine and Health Sciences, Germany, Glutamatergic Receptor Systems, Glutamatergic System, Harms of Too Much Medicine, Institute of Pharmacology: Polish Academy of Sciences, JAMA Network Open, Janssen Research and Development, Journal of Geriatric Care and Research (JGCR), Keck School of Medicine: University of Southern California, KYNA/3-HK, KYNA/KYN, KYNA/QUIN, Kynurenic Acid, Kynurenine Pathway, Marshfield Clinic Health System (USA), Medical College of Georgia: Augusta University, Memantine, Ministry of Health and Solidarity (France), Mismatch Negativity (MMN), Mount Sinai Medical Center (New York), National Institutes of Health (NIH), National Institutes of Health (US), Neurotransmitter Systems in Alzheimer’s Disease, New Cross Hospital, New Cross Hospital: Royal Wolverhampton NHS Trust, NMDA (N-Methyl-D-Aspartate), Over-Treatment, Oxidative Stress, Paola Barbarino: Alzheimer’s Disease International, Poland, Polish Academy of Sciences, Prescrire in English [the Prescriber] / Rev. Prescrire, Reducing Waste in Dementia Care, Reducing Waste in the NHS, Rivastigmine, Royal Wolverhampton NHS Trust, Serge Gauthier: ADI’s Medical and Scientific Advisory Panel (MSAP), Society of Biological Psychiatry (SOBP), Southern Illinois University, Southern Illinois University School of Medicine, Synaptec Inc (Florida), Too Much Medicine, United States, University of Alabama at Birmingham, University of Cambridge, University of Southern California, USA
|
Leave a comment
More on the Disproportionately High Impact of Dementia Upon Women (GADAA)
Summary Women comprise roughly 65% of people with dementia in the UK. They are disproportionately affected by the condition in terms of having to assume caring responsibilities. The main section headings in this report comprise: Chapter 1: Key Challenges. An … Continue reading →
Posted in Alzheimer's Society, Alzheimer’s Disease International (ADI), Charitable Bodies, Commissioning, Community Care, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, International, Management of Condition, Mental Health, Models of Dementia Care, National, Non-Pharmacological Treatments, Person-Centred Care, Quick Insights, Standards, Statistics, UK, Universal Interest, Wales, World Health Organization (WHO)
|
Tagged 70th World Health Assembly (May 2017), 70th World Health Assembly Adopted Global Action Plan on Dementia, Age International, Ageing and Society, Ageing Population, Ageing Workforce, Alzheimer's Association International Conference (Los Angeles 2019), Alzheimer’s Association International Conference (AAIC®2019), Amy Little: Global Alzheimer’s & Dementia Action Alliance / Alzheimer’s Society, Association for Dementia Studies: University of Worcester, Brain Connectivity: Sex-Specific Differences in Vulnerability to Tau Accumulation, Burden of Alzheimer’s Disease, Burden of Dementia (Statistics), Burden on Caregivers, Caregiver Burden, Carer Awareness, Carer Experience, Carer Fatigue, Carer Support, Carers and Families, Chris Roles: Age International, Commissioning for Carers, Convention on the Elimination of All Forms of Discrimination against Women (CEDAW), Dementia Alliance International, Dementia Prevalence: Statistics and Projections, Differential Impact of Dementia (Gender-Related), Discrimination, Disease Burden, Disproportionate Burden of Dementia on Women, Disproportionate Impact of Dementia on Women, Domestic Violence, Dr Clare Walton: Research Manager at Alzheimer's Society, Dr Saskia Sivananthan: World Health Organisation, Dr Tarun Dua: World Health Organisation, Empowering Change: A National Strategy for Dementia in the Maltese Islands 2015–2023, Exposure to Violence, Family Carers, Female to Male Sex Ratios in Ageing, GADAA Secretariat, GADAA Steering Committee, GADAA: Global Alzheimer’s and Dementia Action Alliance, Gavin Terry: Policy Manager at Alzheimer’s Society, Gender (Sex), Gender and Inequalities in Health in Later Life, Gender Issues of Living With or Caring For Persons With Dementia, Gender Norms, Global Action Plan for Public Health Response to Dementia (WHO), Global Alzheimer’s and Dementia Action Alliance (GADAA), Global and National Perspective on Dementia (National Assembly for Wales), Global Burden of Dementia, Global Plan of Action on the Public Health Response to Dementia 2017–2025, Impact of Caring on Ability to Work, Impact of Caring on Carers, Impact of Dementia on Women: CEDAW, Impact of Dementia on Women: International Civil Society Responses, Impact of Dementia on Women: International Frameworks, Impact of Dementia on Women: National Responses, Impact of Dementia on Women: Regional Frameworks, Impact of Dementia on Women: Sustainable Development Goals, Impact of Dementia on Women: the Overlooked Majority, Impact of Dementia on Women: WHO Global Action Plan, Impact of Dementia on Women: Women as Care Partners, Informal Carers, Informal Workforce, International Legislation, International Policy Documents, James Smith: Alzheimer’s Disease International, Jeremy Hughes CBE: Chief Executive of the Alzheimer’s Society, Kate Swaffer: Chair of Dementia Alliance International, Living Alone, Long-Term Impact of Dementia on Women as Family and Formal Caregivers, Luxemburg, Luxemburg: Le Plan d’action National Maladies Démentielles, Marc Wortmann: Alzheimer’s Disease International, Martina Kane: Alzheimer's Society, Men vs. Women (Diseease Prevalence), National Assembly for Wales, National Dementia Plans and Strategies: Lack of Gender-Sensitivity, National Policy Documents, Older Carers, Plan Nacional de Demencias para la República Oriental del Uruguay, Prevalence of Dementia, Prevalence of Unpaid Care, Professor Dawn Brooker, Recorded Dementia Prevalence, Reducing Discrimination, Scotland’s National Dementia Strategy, Scotland’s National Dementia Strategy: 2013-16, Sex-Specific Differences in Brain Connectivity, Sex-Specific Genetic Risk Factors, Stigma, Stigma and Discrimination, Sustainable Development Goals (SDGs) of the 2030 Agenda for Sustainable Development: United Nations (UN), Switzerland, Switzerland: Stratégie Nationale en Matière de Démence 2014–2019, University of Worcester, University of Worcester: Association for Dementia Studies, Unpaid Caregivers (Carers), Unpaid Carers, Violence, Violence Against Women, WHO Global Action Plan, WHO Global Action Plan on the Public Health Response to Dementia 2017-2025, WHO Global Dementia Observatory (GDO), Women and Dementia, Women as Care Partners, Women in Dementia Care Workforce, World Health Assembly, World Health Assembly (WHA)
|
Leave a comment
Healthcare Pathways For People Living With Dementia: World Alzheimer Report 2016 (Alzheimer’s Disease International)
Summary The World Alzheimer Report 2016, entitled “Improving healthcare for people living with dementia” reviews evidence on aspects of healthcare for people with dementia and suggests how improvements and efficiency savings can be made. The authors are against over-specialization of … Continue reading →
Posted in Acute Hospitals, Alzheimer’s Disease International (ADI), Charitable Bodies, Commissioning, Community Care, Diagnosis, End of Life Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Quick Insights, Standards, Statistics, Systematic Reviews, UK, Universal Interest
|
Tagged 10/66 Dementia Research Group, Access to Palliative Care, ADI’s World Alzheimer Reports, Advance Care Planning (ACP), Ageing Population, Ageing Society, Alzheimer’s Disease International (ADI), Alzheimer’s Disease International’s 10/66 Dementia Research Group, Benefits of Case Management, Better Policies for People with Dementia, Canada, Canadian Centre for Family Medicine Family Health Team (CCFM-FHT) Ontario Memory Clinic, Canadian Comfort Care Booklet, Canadian Comfort Care Principles, Canadian Mild Dementia Knowledge Transfer Toolkit, Care Coordination / Case Management Approaches For People With Dementia Living at Home, Care Coordination and Navigation, Case Management for Dementia, Challenges of Living with Dementia, China, Clinical Practice Guidelines and Care Pathways for People with Dementia Living in the Community (Queensland University of Technology), Community Care, Community Care Services, Community-Based Care, Community-Based Care for People With Dementia, Cost Implications of Dementia Healthcare Pathways, Counter-Factual Service Modelling, Dedicated Care Coordination, Dementia Care in Acute General Hospitals, Dementia Care Pathways, Dementia Healthcare Pathways, Dementia Post-Diagnostic Care and Support, Dementia Research Priorities For Healthcare Sector (WHO Research Prioritization Exercise), Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Dementia: Prevalence and Detection, Early Detection of Alzheimer’s Disease, European Association for Palliative Care White Paper, Global Action Against Dementia, Global Burden of Dementia, Global Context, Global Costs of Dementia, Global Dementia Crisis, Global Dementia Crisis: Adaptations to Services, Global Dementia Crisis: Re-Balancing of Funding For Services, Global Dementia Crisis: Re-Balancing of Services, Global Health, Global Observatory for Ageing and Dementia Care, Global Observatory for Ageing and Dementia Care: King’s College London, Global Outlook, Health Service and Population Research Department: King’s College London, Improving Healthcare For People Living With Dementia: World Alzheimer Report 2016, Improving Outcomes for People Living With Dementia, Indonesia, Integrated and Community-Based Care, Integration of Primary Secondary and Community Care, King’s College London, Living with Dementia, London School of Economics and Political Science (LSE), LSE's Personal Social Services Research Unit (PSSRU), Managing Comorbidity and Complexity, Mexico, Palliative Care, Personal Social Services Research Unit (PSSRU), Personal Social Services Research Unit (PSSRU): London School of Economics and Political Science, Primary Care, Professor Martin Knapp: Director of the Personal Social Services Research Unit at the London School of Economics and Political Science (LSE), PSSRU at London School of Economics and Political Science, Queensland University of Technology Clinical Practice Guidelines and Care Pathways for People with Dementia Living in the Community, South Africa, South Korea, Switzerland, Systematic Reviews and Meta-Analyses, Task-Sharing, Task-Shifting, Typical Duration of Care Inputs Across the Care Pathway, Typical Intensity / Frequency of Care Inputs Across the Care Pathway, World Alzheimer Report 2016, World Health Organization Mental Health Gap Action Programme (mhGAP) Evidence Based Guidelines
|
Leave a comment
World Alzheimer’s Day and World Alzheimer’s Month 2016 (Alzheimer’s Disease International)
Summary Information is available from Alzheimer’s Disease International (ADI) concerning World Alzheimer’s Month (September); and World Alzheimer’s Day 2016, on September 21st 2016. The theme for this year’s World Alzheimer’s Month campaign is “Remember Me”. World Alzheimer’s Month is a … Continue reading →
Posted in Alzheimer's Society, Alzheimer’s Disease International (ADI), Charitable Bodies, In the News, International, Mental Health, Models of Dementia Care, Patient Information, Person-Centred Care, Personalisation, Quick Insights, Scotland, UK, Universal Interest
|
Tagged 20000 Reasons Campaign (Alzheimer's Society: Northern Ireland), 45000 Reasons Campaign (Alzheimer's Society: Wales), Albania, Argentina, Armenia, Aruba, Australia, Austria, Awareness, Awareness Campaigns, Awareness Raising, Bahrain, Bangladesh, Barbados, Belgium, Bermuda, Bolivia, Brazil, Brunei, Bulgaria, Canada, Carey Mulligan, Carey Mulligan: UK Global Dementia Friends Ambassador, Cayman Islands, Chile, China, Chinese Taipei, Colombia, Costa Rica, Croatia, Cuba, Curaçao, Cyprus, Czech Republic, Dementia Awareness Campaigns, Dementia Awareness Raising, Dementia Friends, Denmark, Dominican Republic, Ecuador, Egypt, El Salvador, Ethiopia, Finland, France, Germany, Ghana, Gibraltar, Global Outlook, Greece, Guatemala, Honduras, Hong Kong SAR, Hungary, Iceland, India, Indonesia, Iran, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kenya, Lebanon, Luxembourg, Macau (SAR China), Macau SAR, Macedonia, Madagascar, Malaysia, Malta, Mauritius, Mexico, Monaco, Morocco, Namibia, Nepal, Netherlands, New Zealand, Nicaragua, Nigeria, Norway, Pakistan, Peru, Philippines, Poland, Portugal, PR China, Puerto Rico, Romania, Russia, Saudi Arabia, Scotland, Serbia, Singapore, Sint Maarten, Slovak Republic, Slovenia, South Africa, South Korea, Spain, Sri Lanka, St Kitts and Nevis, Suriname, Sweden, Switzerland, Syria, TADA Chinese Taipei, Thailand, Trinidad and Tobago, Tunisia, Turkey, Ukraine, Uruguay, USA, Venezuela, World Alzheimer's Month 2016 (Remember Me), World Alzheimer’s Day 2016, World Alzheimer’s Month 2016, Zimbabwe
|
Leave a comment
Faintest Hints of Promise From a Recent Dementia Drug Trial? (BBC News / Alzheimer’s Association International Conference)
Summary Data from a recent trial involving 891 patients, presented at the Alzheimer’s Association International Conference in Toronto this week, indicates that an experimental new drug (LMTX) appears to slow the death of brain cells and preserve mental function in … Continue reading →
Posted in Alzheimer’s Disease International (ADI), BBC News, Charitable Bodies, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Management of Condition, Models of Dementia Care, Pharmacological Treatments, Quick Insights, Universal Interest
|
Tagged Abnormal Proteins (Tau), Alzheimer Disease and Related Disorders Research Unit of the McGill University Research Centre for Studies in Aging (Douglas Mental Health University Institute), Alzheimer's Disease Research Unit: McGill University (Canada), Alzheimer’s Association, Alzheimer’s Association International Conference® (AAIC®) 2016, BBC Health News, Degenerative Tauopathy, Dementia Research, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Douglas Mental Health University Institute: McGill University Research Centre for Studies in Aging, Dr Serge Gauthier: Director of Alzheimer's Disease Research Unit at McGill University in Canada, Drug Development for Alzheimer's Disease, Drug Discovery Programmes, Drug Identification, Drug Trials, Drug Trials Failure Rate, Drug-Development Pipeline, Drugs for Treatment of Alzheimer’s Disease, Global Dementia Research, Leuco-methylthioninium-bis (hydromethanesulfonate) (LMTM), Leucomethylthioninium Salts (LMTX), LMTM Monotherapy, LMTX, Ltd., Neurodegeneration, Neurodegenerative Disease Research, Research and Development, Research and Innovation, Research Commitment, Tau, Tau Aggregation, Tau Aggregation Inhibitor Therapy, Tau Aggregation Inhibitors, Tau Pathology, Tau Tangles, Tau-Targeting Drugs, Tauopathy, TauRX, TauRx Therapeutics, Treatment and Prevention of Dementia
|
Leave a comment
